GSK to put £50M into Cambridge University partnership; Angelini’s new deal

Plus, news about Take­da, Fore­see Phar­ma­ceu­ti­cals and Capri­cor Ther­a­peu­tics:

GSK, Cam­bridge Uni­ver­si­ty team up on im­mune dis­eases: The UK drug­mak­er is pour­ing £50 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.